203 related articles for article (PubMed ID: 1719729)
1. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
2. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
4. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
5. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
6. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
7. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
[TBL] [Abstract][Full Text] [Related]
8. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
9. [Hemodilution in peripheral arterial occlusive disease].
Becsi C; Wehofer D; Weidinger P
Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
[No Abstract] [Full Text] [Related]
10. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
Kiesewetter H; Jung F; Birk A; Spitzer S
Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
[TBL] [Abstract][Full Text] [Related]
11. [Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Dtsch Med Wochenschr; 1986 Aug; 111(35):1307-12. PubMed ID: 2427301
[TBL] [Abstract][Full Text] [Related]
12. [Hemodilution in acute arterial circulatory disorders of the retina].
Arend O; Hoberg A; Bertram B; Reim M; Wolf S
Acta Med Austriaca; 1991; 18 Suppl 1():66-8. PubMed ID: 1719735
[TBL] [Abstract][Full Text] [Related]
13. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
Kiesewetter H; Blume J; Jung F; Spitzer S; Wenzel E
J Intern Med; 1990 Feb; 227(2):107-14. PubMed ID: 1688914
[TBL] [Abstract][Full Text] [Related]
14. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
15. Hematocrit dependent changes of muscle tissue oxygen supply in the lower limb muscle of patients with intermittent claudication.
Höffkes HG; Ehrly AM
Vasa; 1992; 21(4):350-4. PubMed ID: 1485467
[TBL] [Abstract][Full Text] [Related]
16. Optimal hematocrit in patients with intermittent claudication. Exercise-induced muscle tissue oxygen pressure after stepwise hemodilution.
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Acta Med Austriaca; 1991; 18 Suppl 1():16-9. PubMed ID: 1950385
[TBL] [Abstract][Full Text] [Related]
17. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hemodilution on systemic and capillary hematocrit].
Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
[TBL] [Abstract][Full Text] [Related]
19. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
Kiesewetter H; Blume J; Bulling B; Gerhards M; Jung F; Radtke H; Franke RP
Dtsch Med Wochenschr; 1984 Nov; 109(48):1844-7. PubMed ID: 6209081
[TBL] [Abstract][Full Text] [Related]
20. [Results of the Berlin HOT/UVB comparative study in patients with peripheral arterial occlusive disorders].
Paulitschke M; Turowski A; Lerche D
Z Gesamte Inn Med; 1992 Apr; 47(4):148-53. PubMed ID: 1595300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]